Tuesday 22nd May
Home » Archives
Lilly Oncology to Highlight Final Results for Phase III Study in Most Common Form of Lung Cancer
Written on 14 May, 2012 at 9:00 in Drugs/Pharmaceuticals, Featured | viewed 1 views times | 0 Comments
INDIANAPOLIS, May 14, 2012 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) will present data from more than 25 studies at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill. from June 1 –... (Continue reading)
Air Products Introduces New Epoxy Curing Agents
Written on 7 May, 2012 at 15:00 in Drugs/Pharmaceuticals, Featured, Health | viewed 0 views times | 0 Comments
LEHIGH VALLEY, Pa., May 7, 2012 /PRNewswire/ — Air Products (NYSE: APD) today introduced a number of new waterborne and solvent-free epoxy curing agents as well as its new isocynate curing agents, or polycarbamide technology, for use in a variety... (Continue reading)
ADVENTRX Pharmaceuticals to Sponsor & Present at the Martin Center’s 2012 Sickle Cell Disease Conference
Written on 16 Apr, 2012 at 8:01 in Drugs/Pharmaceuticals, Health | viewed 4 views times | 0 Comments
SAN DIEGO, April 16, 2012 /PRNewswire/ — ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company is a sponsor of and will be presenting at the Martin Center’s 2012 Indiana Statewide Sickle Cell Disease Conference at the Indiana... (Continue reading)
FDA Approves Amyvid (Florbetapir F 18 Injection) for Use in Patients Being Evaluated for Alzheimer’s Disease and Other Causes of Cognitive Decline
Written on 6 Apr, 2012 at 22:09 in Drugs/Pharmaceuticals, Featured | viewed 0 views times | 0 Comments
INDIANAPOLIS, April 6, 2012 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, today announced the U.S. Food and Drug Administration (FDA) approval of Amyvid(TM), a radioactive diagnostic agent indicated for... (Continue reading)
CouponCabin.com Launches Prescription Drug Coupons Section
Written on 5 Apr, 2012 at 7:00 in Drugs/Pharmaceuticals | viewed 0 views times | 0 Comments
WHITING, Ind., April 5, 2012 /PRNewswire/ — As costs for prescription medications rise, along with their co-pays, prescription drug coupons have become a popular way to save money on staying healthy. In fact, nearly 19 million Americans report they have... (Continue reading)
BYETTA Approved for Use with Basal Insulin in Europe
Written on 25 Mar, 2012 at 8:00 in Drugs/Pharmaceuticals, Health | viewed 4 views times | 0 Comments
SAN DIEGO and INDIANAPOLIS, March 24, 2012 /PRNewswire/ — Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced today that the European Commission has granted marketing authorization to BYETTA® (exenatide twice-daily) as an adjunctive therapy to... (Continue reading)
Lilly Pledges $100,000 to American Red Cross’ Tornado Disaster Relief Efforts
Written on 5 Mar, 2012 at 9:18 in Business, Charities, Corporate Responsibility/Ethics, Drugs/Pharmaceuticals, Featured, Lifestyle, Philanthropy | viewed 5 views times | 0 Comments
INDIANAPOLIS, March 5, 2012 /PRNewswire/ — The Eli Lilly and Company (NYSE: LLY) Foundation today pledged $100,000 to the American Red Cross for its tornado disaster relief efforts. The donation will support families and communities affected by devastating tornadoes that... (Continue reading)
Lilly Introduces Global ‘Innovation Starts Here’ Initiative to Foster Innovation and Quality Science
Written on 28 Feb, 2012 at 18:11 in Awards/Achievements, Biotechnology, Business, Drugs/Pharmaceuticals, Featured, Health, Medical/Dental Technology, Technology | viewed 2 views times | 0 Comments
BRUSSELS, Feb. 28, 2012 /PRNewswire/ — Eli Lilly and Company (NYSE:LLY) today announced the launch of its global Innovation Starts Here initiative which supports Lilly’s commitment to speeding the delivery of innovative new medicines to patients around the world. Two... (Continue reading)
The Centers for Disease Control & Prevention Signs Vaccine Warehouse and Distribution Contract with Sentry BioPharma Services
Written on 21 Feb, 2012 at 6:05 in Biotechnology, Business, Drugs/Pharmaceuticals, Health, Technology | viewed 0 views times | 0 Comments
INDIANAPOLIS, Feb. 21, 2012 /PRNewswire/ — Sentry BioPharma Services, a provider of global biopharmaceutical cGMP warehouse, supply chain management, prescription drug distribution and clinical packaging services, announced today that the Centers for Disease Control & Prevention (CDC) selected Sentry to... (Continue reading)
CHMP Recommends Approval of BYETTA for Use With Basal Insulin
Written on 17 Feb, 2012 at 7:53 in Biotechnology, Business, Drugs/Pharmaceuticals, Health, Medical/Dental, Technology | viewed 0 views times | 0 Comments
SAN DIEGO and INDIANAPOLIS, Feb. 17, 2012 /PRNewswire/ — Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has... (Continue reading)
Hot Topics in Drugs/Pharmaceuticals
- Lilly Pledges $100,000 to American Red Cross’ Tornado Disaster Relief Efforts - 5 views
- BYETTA Approved for Use with Basal Insulin in Europe - 4 views
- ADVENTRX Pharmaceuticals to Sponsor & Present at the Martin Center’s 2012 Sickle Cell Disease Conference - 4 views
- New Study Evaluates Cialis in parallel with Tamsulosin in Men with Signs and Symptoms Suggestive of Benign Prostatic Hyperplasia - 2 views
- Lilly Introduces Global ‘Innovation Starts Here’ Initiative to Foster Innovation and Quality Science - 2 views
- Lilly Oncology to Highlight Final Results for Phase III Study in Most Common Form of Lung Cancer - 1 views
- The Centers for Disease Control & Prevention Signs Vaccine Warehouse and Distribution Contract with Sentry BioPharma Services - 0 views
- CHMP Recommends Approval of BYETTA for Use With Basal Insulin - 0 views
- Lilly Releases Its Most Comprehensive Corporate Responsibility Report - 0 views
- CouponCabin.com Launches Prescription Drug Coupons Section - 0 views
- The Centers for Disease Control & Prevention Signs Vaccine Warehouse and Distribution Contract with Sentry BioPharma Services
(0.00 out of 5) - CHMP Recommends Approval of BYETTA for Use With Basal Insulin (0.00 out of 5)
- New Study Evaluates Cialis in parallel with Tamsulosin in Men with Signs and Symptoms Suggestive of Benign Prostatic Hyperplasia (0.00 out of 5)
- Lilly Releases Its Most Comprehensive Corporate Responsibility Report (0.00 out of 5)
- Lilly Introduces Global ‘Innovation Starts Here’ Initiative to Foster Innovation and Quality Science (0.00 out of 5)
- Lilly Pledges $100,000 to American Red Cross’ Tornado Disaster Relief Efforts (0.00 out of 5)
- BYETTA Approved for Use with Basal Insulin in Europe (0.00 out of 5)
- CouponCabin.com Launches Prescription Drug Coupons Section (0.00 out of 5)
- ADVENTRX Pharmaceuticals to Sponsor & Present at the Martin Center’s 2012 Sickle Cell Disease Conference (0.00 out of 5)
- FDA Approves Amyvid (Florbetapir F 18 Injection) for Use in Patients Being Evaluated for Alzheimer’s Disease and Other Causes of Cognitive Decline (0.00 out of 5)
- The Centers for Disease Control & Prevention Signs Vaccine Warehouse and Distribution Contract with Sentry BioPharma Services - 0 votes
- CHMP Recommends Approval of BYETTA for Use With Basal Insulin - 0 votes
- New Study Evaluates Cialis in parallel with Tamsulosin in Men with Signs and Symptoms Suggestive of Benign Prostatic Hyperplasia - 0 votes
- Lilly Releases Its Most Comprehensive Corporate Responsibility Report - 0 votes
- Lilly Introduces Global ‘Innovation Starts Here’ Initiative to Foster Innovation and Quality Science - 0 votes
- Lilly Pledges $100,000 to American Red Cross’ Tornado Disaster Relief Efforts - 0 votes
- BYETTA Approved for Use with Basal Insulin in Europe - 0 votes
- CouponCabin.com Launches Prescription Drug Coupons Section - 0 votes
- ADVENTRX Pharmaceuticals to Sponsor & Present at the Martin Center’s 2012 Sickle Cell Disease Conference - 0 votes
- FDA Approves Amyvid (Florbetapir F 18 Injection) for Use in Patients Being Evaluated for Alzheimer’s Disease and Other Causes of Cognitive Decline - 0 votes
Subscription
You can subscribe by RSS feed or by e-mail to receive news updates and breaking stories.
Follow us on Twitter
Our School – Written by Robert L. Hoy- We can’t wait any longer for reform February 28, 2012 Robert L. Hoy
- Reform comes too slowly December 19, 2011 Robert L. Hoy
- An obstacle for parents who want vouchers November 17, 2011 Robert L. Hoy
- Agreeing to disagree October 24, 2011 Robert L. Hoy
- A deserving award for Bennett September 16, 2011 Robert L. Hoy
- The choice is theirs August 19, 2011 Robert L. Hoy
- Teachers matter the most July 19, 2011 Robert L. Hoy
- Yes, parents should get voucher money July 1, 2011 Robert L. Hoy
- Granting parents’ wishes June 27, 2011 Robert L. Hoy
- Reforms open wide the possibilities June 16, 2011 Robert L. Hoy
